The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of a phase 2 trial of ribociclib and letrozole in patients with either relapsed estrogen receptor (ER)-positive ovarian cancers or relapsed ER-positive endometrial cancers.
 
Gerardo Colon-Otero
Research Funding - Novartis (Inst)
 
S. John Weroha
No Relationships to Disclose
 
Valentina Zanfagnin
No Relationships to Disclose
 
Nathan R. Foster
No Relationships to Disclose
 
Erik Asmus
No Relationships to Disclose
 
Andrea Elisabeth Wahner Hendrickson
No Relationships to Disclose
 
Aminah Jatoi
No Relationships to Disclose
 
Matthew Stephen Block
Research Funding - Bristol-Myers Squibb; Genentech/Roche; Immune Design; Marker, Inc.; Merck; Pharmacyclics
 
Carrie L Langstraat
No Relationships to Disclose
 
Gretchen Elizabeth Glaser
No Relationships to Disclose
 
Tri Dinh
No Relationships to Disclose
 
Matthew Robertson
No Relationships to Disclose
 
John Kelly Camoriano
No Relationships to Disclose
 
Kristina Butler
No Relationships to Disclose
 
John A. Copland
No Relationships to Disclose